Trials / Conditions / Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

14 registered clinical trials studyying Polyradiculoneuropathy, Chronic Inflammatory Demyelinating — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CI NCT05327114	Janssen Research & Development, LLC	Phase 2 / Phase 3
Completed	Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenoty NCT04742374	Centre Hospitalier Universitaire de Nīmes	EARLY_Phase 1
Unknown	A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy NCT05877040	Istituto Clinico Humanitas	Phase 2
Completed	Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy NCT06325943	Istituto Clinico Humanitas	Phase 3
Completed	Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyel NCT03008733	Centre Hospitalier Universitaire de Nice	N/A
Terminated	A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 NCT03275740	Pfizer	Phase 1
Unknown	sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN NCT02271724	University of Aarhus	—
Completed	Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory D NCT02027701	CSL Behring	Phase 3
Completed	Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropat NCT01017159	University of Aarhus	Phase 2
Completed	Study of CIDP Patients During IVIG Treatment NCT00305266	University of Aarhus	—
Completed	Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT00220740	Grifols Therapeutics LLC	Phase 3
Completed	Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneur NCT00004939	National Center for Research Resources (NCRR)	Phase 3
Completed	Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated P NCT00004286	National Center for Research Resources (NCRR)	Phase 3
Completed	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflam NCT00004772	National Center for Research Resources (NCRR)	Phase 3